Q3 EPS Forecast for UnitedHealth Group Decreased by Analyst

UnitedHealth Group Incorporated (NYSE:UNH) – Zacks Research lowered their Q3 2025 EPS estimates for shares of UnitedHealth Group in a research note issued on Tuesday, August 12th. Zacks Research analyst D. Chatterjee now forecasts that the healthcare conglomerate will post earnings of $3.07 per share for the quarter, down from their prior estimate of $6.77. The consensus estimate for UnitedHealth Group’s current full-year earnings is $29.54 per share. Zacks Research also issued estimates for UnitedHealth Group’s Q4 2025 earnings at $2.14 EPS, FY2025 earnings at $16.49 EPS, Q1 2026 earnings at $5.12 EPS, Q2 2026 earnings at $4.32 EPS, Q3 2026 earnings at $4.64 EPS, Q4 2026 earnings at $4.55 EPS, FY2026 earnings at $18.63 EPS, Q1 2027 earnings at $5.50 EPS, Q2 2027 earnings at $4.53 EPS and FY2027 earnings at $21.36 EPS.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%. The business’s revenue was up 12.9% on a year-over-year basis. During the same period in the previous year, the firm earned $6.80 EPS.

Several other research firms also recently weighed in on UNH. Baird R W downgraded shares of UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research report on Thursday, July 31st. KeyCorp decreased their target price on UnitedHealth Group from $400.00 to $350.00 and set an “overweight” rating on the stock in a report on Wednesday, July 30th. Mizuho cut their price target on UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating for the company in a report on Friday, May 16th. Wall Street Zen downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Saturday, May 24th. Finally, Argus lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Monday, April 21st. Three research analysts have rated the stock with a sell rating, seven have assigned a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Hold” and a consensus target price of $366.52.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $271.92 on Thursday. The firm’s 50 day moving average price is $289.37 and its 200-day moving average price is $401.34. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock has a market capitalization of $246.27 billion, a PE ratio of 11.78, a price-to-earnings-growth ratio of 1.69 and a beta of 0.43. UnitedHealth Group has a twelve month low of $234.60 and a twelve month high of $630.73.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be paid a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 3.3%. UnitedHealth Group’s payout ratio is presently 38.30%.

Insider Activity at UnitedHealth Group

In other news, CEO Patrick Hugh Conway sold 589 shares of the company’s stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the sale, the chief executive officer directly owned 10,398 shares of the company’s stock, valued at $3,171,390. This represents a 5.36% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Stephen J. Hemsley bought 86,700 shares of the business’s stock in a transaction that occurred on Friday, May 16th. The stock was acquired at an average cost of $288.57 per share, with a total value of $25,019,019.00. Following the completion of the acquisition, the chief executive officer owned 679,493 shares of the company’s stock, valued at $196,081,295.01. This represents a 14.63% increase in their position. The disclosure for this purchase can be found here. 0.28% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On UnitedHealth Group

Large investors have recently added to or reduced their stakes in the stock. Citizens National Bank Trust Department increased its position in UnitedHealth Group by 1.0% during the first quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate’s stock valued at $9,368,000 after acquiring an additional 170 shares during the last quarter. Fort Washington Investment Advisors Inc. OH boosted its stake in shares of UnitedHealth Group by 0.3% during the 1st quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate’s stock worth $277,641,000 after purchasing an additional 1,465 shares during the period. Sherbrooke Park Advisers LLC purchased a new stake in UnitedHealth Group in the 4th quarter worth about $515,000. Full Sail Capital LLC boosted its position in shares of UnitedHealth Group by 2.1% during the fourth quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate’s stock valued at $815,000 after buying an additional 33 shares during the period. Finally, Soros Fund Management LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter worth approximately $39,413,000. 87.86% of the stock is owned by institutional investors.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.